Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Fabio Grizzi

Fabio Grizzi

Professor
Humanitas Clinical and Research Center
Italy

Biography

Biography Professor Fabio Grizzi graduated in Biological Sciences from the University of Milan in 1995 and, in the year, received the Steven Newburgh Annual Award for his contributions to the field of basic and applied biomedical research. In 2001, he was appointed Adjunct Assistant Professor at the Department of Internal Medicine and Hematology & Oncology at Texas Tech University Health Sciences Center in Lubbock, Texas, USA. In 2008, he was invited to become a Member of the National Cancer Institute-sponsored Pilot Cancer Antigen Prioritization Process, of the US National Institute of Health. In 2012, he was invited to become a Member of the worldwide validation of the Immunoscore on colon cancer. He is currently working as Chief of the Histology Laboratory at the Humanitas Research Hospital, Rozzano, Milan, Italy. In 2015 he was appointed Teacher at the Humanitas University, Faculty of Medicine for the course: "Building bodies: from gametes to organs, SSD BIO/17 Histology". He is Member of the Editorial Board of various scientific Journals and serves as Reviewer for prestigious Journals. He has published more than 170 peer-reviewed articles (H-index = 26) and twenty-six book chapters, and made more than 300 presentations at national and international Congresses, and has recently been commissioned by Springer Publishing to prepare a book entitled “The Complexity of Cancer”, which will be published in 2018.

Research Interest

Research Interests His main field of investigation concerns the complex dynamics underlying the behavior of cancers of unrelated histological origin, for which he uses a translational approach with the aim of developing new therapeutic strategies. He is also involved in studying tumor neovascularity, environment/cancer interactions and cancer-related inflammation. Digital pathology, telepathology and the development of computer-aided mathematical models are also key-areas of application and investigation.